- Zim Nurses Begin Nationwide Stay-Away, Down Tools Over Pay Dispute
- Zimbabwean Pharmacist Tackles Health Misinformation One Book at a Time with Seven-Book Series
- 8 things you need to know about the BA.3.2 ‘Cicada’ variant of COVID-19
- Zimbabwean Company Launches Drone Technology to Deliver Medicines and Blood Products
- Two LGBTIQ-Linked Zim NGOs Rejected Under New PVO Decisions
Zim among top priority lenacapavir recipients as Gilead licenses Hetero
By Kuda Pembere With Zimbabwe being among the 18 top-priority recipients of lenacapavir an HIV preventive drug pending local medicines regulatory approvals, Gilead Sciences, the principal maker has granted a non-exclusive license to leading India headquartered pharmaceutical manufacturer Hetero Group of Companies to manufacture and supply the drug. Gilead’s decision comes following much advocacy by
Read MoreInterventions contribute to HIV reduction in Mash Central
By Kuda Pembere in Mvurwi Several interventions have been credited to the reduction of HIV prevalence in Mashonaland Central with the province now ranking the fifth highest in the country. Despite Mazowe topping the list in the past two years, due to some targeted interventions, it has now been overtaken by Bindura where the Provincial
Read MoreHIV Positive Zimbabwean Mothers Celebrate Life Of Healthy Choices and Healthy Children
By Takunda Mandura Having been diagnosed with HIV during her first pregnancy 15 years ago, Moud Chinembiri, now a mother of two children, has defied the odds and looked the beast in the eye. Now her child whom she had when she had a positive HIV diagnosis is attending high school and is HIV-negative, a
Read MoreZimbabwe Needs To Revive Abstinence Message In HIV Programming
By Michael Gwarisa While Zimbabwe has made significant strides in addressing the HIV burden, there is a need for renewed messaging regarding HIV prevention to sustain the gains realised, health experts have said. Zimbabwe is among the few African countries that have attained the UNIADS 95-9-95 targets in adults. Over the past four years, there
Read MoreOver 20 Zimbabwean MPs Appointed Into Global Parliamentary Platform on HIV and AIDS
By Michael Gwarisa A new Global Parliamentary Platform on HIV and AIDS has been established at the ongoing International AIDS Conference in Munich, Germany in a bid to build momentum to end AIDS ahead of the 2030 target. The new platform is set to provide the space, tools, and other resources to unite, strengthen, and
Read MoreUN urges Gilead to ‘make history’ with game-changing HIV drug
Gilead could bring the AIDS pandemic towards an end if the US pharmaceutical giant opens up access to its game-changing new HIV drug, the head of UNAIDS told AFP. Winnie Byanyima urged Gilead to “make history” by allowing generic manufacturing of Lenacapavir, a twice-yearly injectable antiretroviral medication used to treat HIV patients. She urged Gilead to open
Read MoreHIV vaccines tested in PrEPVacc fail to reduce infections
The results of the PrEPVacc HIV vaccine trial conducted in Eastern and Southern Africa, which ran between 2020 and 2024, show conclusively that neither of the two experimental vaccine regimens tested reduced HIV infections among the study population. Vaccinations in the PrEPVacc trial were stopped in November 2023 (and publicly announced in December 2023) when
Read More“Ending AIDS is impossible if we do not prioritize children” – EGPAF
By Staff Reporter MUNICH, GERMANY – 22 July 2024 – The UNAIDS Global Report, “The Urgency of Now: AIDS at a Crossroads,” released today, says “ending AIDS as a public health threat is achievable by 2030 but that success is being threatened by pushes to reduce funding and to restrict human rights.” Challenges faced by
Read MoreUS Government to hold talks with Zim for sustainable condom programming funding
By Kuda Pembere The United States Government will hold talks with the Zimbabwean Government pending the withdrawal of condom programming support via the President’s Emergency Plan for AIDS Relief (PEPFAR) in 2026. Public sector condoms in Zimbabwe are mainly funded via PEPFAR which occupies the majority of the market share at 77 percent followed by
Read MoreVisa disaster looming ahead of International AIDS Conference in Munich
Delays in visa processing at German embassies put the participation of people from countries of the global South and of people from vulnerable communities in jeopardy. Deutsche Aidshilfe is now calling for political action. The conference of the International AIDS Society IAS is the world’s largest congress on scientific, socio-political and civic aspects of HIV.
Read More